Tag: plans

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy

New short-term XRP mining contract offers fast rewards and zero entry cost, giving investors a way to earn while XRP consolidates.

Nouveau contrat de minage à court terme offrant des gains rapides sans coût d’entrée, permettant aux investisseurs de générer des revenus pendant la consolidation de XRP.

Bien que le XRP reste confiné dans une fourchette étroite, le nouveau modèle de minage en nuage de PFMCrypto stimule la participation des détenteurs et l’activité de l’écosystème.

While XRP Remains Range-Bound, PFMCrypto’s New XRP Cloud Mining Model Drives Holder Participation and Ecosystem Activity

Frumzi Casino Has Recently Expanded Its Catalogue of Live Dealer Games, In Order to Become One of the Top Choice Amongst Real Money Online Casinos in Canada for Game Variety

Further founding members include the European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis, and RayzeBio, a Bristol Myers Squibb company.

Colorado, USA, June 21, 2025 (GLOBE NEWSWIRE) -- AIXA Miner, eine führende Krypto-Cloud-Mining-Plattform, hat offiziell die FinCEN Money Services Business (MSB)-Zertifizierung, erhalten und ist damit eine der wenigen vollständig regulierten Mining-Plattformen in den USA. Dieser regulatorische Meilenstein hat das Vertrauen der Anleger – insbesondere unter den US-Nutzern – rasch gestärkt und dazu beigetragen, die globale Nutzerbasis von AIXA Miner auf über 5 Millionen aktive Miner zu erweitern.

BOSTON, June 20, 2025 (GLOBE NEWSWIRE) -- The China Fund, Inc. (NYSE: CHN) (the “Fund”) announced today that its Board of Directors (the “Board”) has approved a plan of liquidation and dissolution (the “Plan”) for the Fund. The Plan will be submitted to Fund stockholders for approval at a Special Meeting. The date of the Special Meeting and more detailed information about the proposed liquidation and Plan will be set forth in a proxy statement to be mailed to the Fund’s stockholders in the near future. The Board recommends that the Fund’s stockholders vote for the liquidation of the Fund at the Special Meeting.

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced two upcoming late-breaking poster presentations at the American Diabetes Association 85^th Scientific Sessions, being held from June 20-23 in Chicago, IL.